Envestnet Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-502
Closed -$208K 3674
2021
Q2
$208K Buy
+502
New +$199K ﹤0.01% 3471
2021
Q1
Sell
-665
Closed -$373K 3505
2020
Q4
$373K Sell
665
-1,123
-63% -$712K ﹤0.01% 2809
2020
Q3
$1.25M Buy
1,788
+332
+23% +$259K ﹤0.01% 1888
2020
Q2
$1.15M Buy
1,456
+502
+53% +$379K ﹤0.01% 1883
2020
Q1
$568K Buy
954
+328
+52% +$320K ﹤0.01% 2150
2019
Q4
$712K Sell
626
-250
-29% -$272K ﹤0.01% 2231
2019
Q3
$1.04M Buy
876
+82
+10% +$125K ﹤0.01% 1913
2019
Q2
$1.31M Buy
794
+71
+10% +$123K ﹤0.01% 1781
2019
Q1
$1.47M Buy
723
+23
+3% +$40.5K ﹤0.01% 1646
2018
Q4
$899K Buy
+700
New +$1.07M ﹤0.01% 1808
2018
Q3
Sell
-30
Closed -$61K 1398
2018
Q2
$61K Buy
30
+1
+3% +$2.28K ﹤0.01% 2140
2018
Q1
$64K Buy
29
+1
+4% +$2.54K ﹤0.01% 2063
2017
Q4
$65K Buy
28
+3
+12% +$6.09K ﹤0.01% 2238
2017
Q3
$45K Buy
25
+17
+213% +$23.8K ﹤0.01% 2309
2017
Q2
$11K Sell
8
-1
-11% -$1.21K ﹤0.01% 2691
2017
Q1
$10K Buy
+9
New +$9.18K ﹤0.01% 2782

Other funds holding BLUE

Envestnet Asset Management's BLUE Position: Q3 2021 in Review

Envestnet Asset Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 502 shares — an estimated $208K sold.

Envestnet Asset Management first reported a position in BLUE in Q1 2017 and held it in 16 quarters. The position peaked at $1.47M in Q1 2019. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Envestnet Asset Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Envestnet Asset Management sold 502 bluebird bio shares in Q3 2021, an estimated $208K.
  • Envestnet Asset Management first reported a position in bluebird bio in Q1 2017 and held it in 16 quarters.
  • Envestnet Asset Management's bluebird bio position peaked at $1.47M in Q1 2019.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.